Research programme: Biopolymers + SQP07 - Shasqi
Latest Information Update: 02 Jul 2024
At a glance
- Originator Shasqi
- Class Antineoplastics; Biopolymers; Camptothecins; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer